Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'DESOGESTREL' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 178 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Ferreira, ACP; Montes, MBA; Franceschini, SA; Toloi, MRT
      Effects of two oral contraceptives, containing 30 or 20 mu g of ethinyl estradiol in combination with gestodene, on blood coagulation and fibrinolysis in Brazilian women

      INTERNATIONAL JOURNAL OF FERTILITY AND WOMENS MEDICINE
    2. Bringer, J; Raingeard, I; Lefebvre, P; Renard, E
      Suitable forms of contraception for diabetic women

      DIABETES & METABOLISM
    3. Le, J; Tsourounis, C
      Implanon: A critical review

      ANNALS OF PHARMACOTHERAPY
    4. Clarke, AK; Miller, SJ
      The debate regarding continuous use of oral contraceptives

      ANNALS OF PHARMACOTHERAPY
    5. Kemmeren, JM; Algra, A; Grobbee, DE
      Effect of second and third generation oral contraceptives on lipid metabolism in the absence or presence of the factor V Leiden mutation

      JOURNAL OF INTERNAL MEDICINE
    6. Schleussner, E; Brueckner, T; Brautigam, J; Michels, W
      Influence of two low-dose oral contraceptives on pulsatile gonadotropin secretion

      GYNECOLOGICAL ENDOCRINOLOGY
    7. Roumen, FJME; Apter, D; Mulders, TMT; Deiben, TOM
      Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol

      HUMAN REPRODUCTION
    8. Drapier-Faure, E; Faure, M
      The role of hormone treatments in acne

      ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE
    9. Klinger, G; Piater, T; Jager, R; Kuntzel, B; Schon, R; Hobe, G
      Non-protein bound dienogest in serum and salivary dienogest in women taking the oral contraceptives Certostat (R) and Valette (R)

      PHARMAZIE
    10. Miller, L; Notter, KM
      Menstrual reduction with extended use of combination oral contraceptive pills: Randomized controlled trial

      OBSTETRICS AND GYNECOLOGY
    11. Kamischke, A; Venherm, S; Ploger, D; von Eckardstein, S; Nieschlag, E
      Intramuscular testosterone undecanoate and norethisterone enanthate in a clinical trial for male contraception

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    12. Braendle, W
      An oral contraceptive containing drospirenone - A synthetic progestin withantimineralocorticoid and antiandrogenic properties

      GEBURTSHILFE UND FRAUENHEILKUNDE
    13. Thiboutot, D; Archer, DF; Lemay, A; Washenik, K; Roberts, J; Harrison, DD
      A randomized, controlled trial of a low-dose contraceptive containing 20 mu g of ethinyl estradiol and 100 mu g of levonorgestrel for acne treatment

      FERTILITY AND STERILITY
    14. Gruschke, A; Kuhl, H
      Validity of radioimmunological methods for determining free testosterone in serum

      FERTILITY AND STERILITY
    15. Poindexter, A
      The emerging use of the 20-mu g oral contraceptive

      FERTILITY AND STERILITY
    16. Endrikat, J; Cronin, M; Gerlinger, C; Ruebig, A; Schmidt, W; Dusterberg, B
      Open, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day oral contraceptive regimen with 20 mu g ethinyl estradiol and 75 mu g gestodene and a 21-day regimen with 20 mu g ethinyl estradiol and 150 mu g desogestrel

      CONTRACEPTION
    17. Hennessy, S; Berlin, JA; Kinman, JL; Margolis, DJ; Marcus, SM; Strom, BL
      Risk of venous thromboembolism from oral contraceptives containing gestodene and desogestrel versus levonorgestrel: a meta-analysis and formal sensitivity analysis

      CONTRACEPTION
    18. Foulon, T; Payen, N; Laporte, F; Bijaoui, S; Dupont, G; Roland, F; Groslambert, P
      Effects of two low-dose oral contraceptives containing ethinylestradiol and either desogestrel or levonorgestrel on serum lipids and lipoproteins with particular regard to LDL size

      CONTRACEPTION
    19. Fruzzetti, F; Genazzani, AR; Ricci, C; De Negri, F; Bersi, C; Carmassi, F
      A 12-month clinical investigation with a 24-day regimen containing 15 mu gethinylestradiol plus 60 mu g gestodene with respect to hemostasis and cycle control

      CONTRACEPTION
    20. Merki-Feld, GS; Brekenfeld, C; Migge, B; Keller, PJ
      Nonpalpable ultrasonographically not detectable Implanon rods can be localized by magnetic resonance imaging

      CONTRACEPTION
    21. Knopp, RH; Broyles, FE; Cheung, M; Moore, K; Marcovina, S; Chandler, WL
      Comparison of the lipoprotein, carbohydrate, and hemostatic effects of phasic oral contraceptives containing desogestrel or levonorgestrel

      CONTRACEPTION
    22. Ballagh, SA
      Vaginal ring hormone delivery systems in contraception and menopause

      CLINICAL OBSTETRICS AND GYNECOLOGY
    23. Hilhorst, MJ; Somsen, GW; de Jong, GJ
      Sensitivity enhancement in capillary electrochromatography by on-column preconcentration

      CHROMATOGRAPHIA
    24. Mackie, IJ; Piegsa, K; Furs, SA; Johnson, J; Bounds, W; Machin, SJ; Guillebaud, J
      Protein S levels are lower in women receiving desogestrel-containing combined oral contraceptives (COCs) than in women receiving levonorgestrel-containing COCs at steady state and on cross-over

      BRITISH JOURNAL OF HAEMATOLOGY
    25. Gupta, S
      Weight gain on the combined pill - is it real?

      HUMAN REPRODUCTION UPDATE
    26. Deckers, GH; Schoonen, WGEJ; Kloosterboer, HJ
      Influence of the substitution of 11-methylene, Delta(15), and/or 18-methylgroups in norethisterone on receptor binding, transactivation assays and biological activities in animals

      JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
    27. Schoonen, WGEJ; Deckers, G; de Gooijer, ME; de Ries, R; Mathijssen-Mommers, G; Hamersma, H; Kloosterboer, HJ
      Contraceptive progestins. Various 11-substituents combined with four 17-substituents: 17 alpha-ethynyl, five- and six-membered spiromethylene ethers or six-membered spiromethylene lactones

      JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
    28. Bruni, V; Croxatto, H; De la Cruz, J; Dhont, M; Durlot, F; Fernands, MTMS; Andrade, RP; Weisberg, E; Rhoa, M
      A comparison of cycle control and effect on well-being of monophasic gestodene-, triphasic gestodene- and monophasic desogestrel-containing oral contraceptives

      GYNECOLOGICAL ENDOCRINOLOGY
    29. Palovaara, S; Kivisto, KT; Tapanainen, P; Manninen, P; Neuvonen, PJ; Laine, K
      Effect of an oral contraceptive preparation containing ethinylestradiol and gestodene on CYP3A4 activity as measured by midazolam 1 '-hydroxylation

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    30. Martin, CW; Riley, SC; Everington, D; Groome, NP; Riemersma, RA; Baird, DT; Anderson, RA
      Dose-finding study of oral desogestrel with testosterone pellets for suppression of the pituitary-testicular axis in normal men

      HUMAN REPRODUCTION
    31. Zittermann, A
      Decreased urinary calcium loss and lower bone turnover in young oral contraceptive users

      METABOLISM-CLINICAL AND EXPERIMENTAL
    32. Anawalt, BD; Herbst, KL; Matsumoto, AM; Mulders, TMT; Coelingh-Bennink, HJT; Bremner, WJ
      Desogestrel plus testosterone effectively suppresses spermatogenesis but also causes modest weight gain and high-density lipoprotein suppression

      FERTILITY AND STERILITY
    33. Escobar-Morreale, HF; Lasuncion, MA; Sancho, J
      Treatment of hirsutism with ethinyl estradial-desogestrel contraceptive pills has beneficial effects on the lipid profile and improves insulin sensitivity

      FERTILITY AND STERILITY
    34. Paulus, D; Saint-Remy, A; Jeanjean, M
      Oral contraception and cardiovascular risk factors during adolescence

      CONTRACEPTION
    35. Bassol, S; Alvarado, A; Celis, C; Cravioto, MC; Peralta, O; Montano, R; Novelli, J; Albornoz, H; Kesseru, E; Soares, A; Petracco, A; Isaia, B; Mendes, J; Bahamondes, L; de Melo, NR; Reyes-Marquez, R; Albrecht, G
      Latin American experience with two low-dose oral contraceptives containing30 mu g ethinylestradiol/75 mu g gestodene and 20 mu g ethinylestradiol/150 mu g desogestrel

      CONTRACEPTION
    36. Winkler, UH
      Hemostatic effects of third- and second-generation oral contraceptives: absence of a causal mechanism for a difference in risk of venous thromboembolism

      CONTRACEPTION
    37. Lawrenson, R; Farmer, R
      Venous thromboembolism and combined oral contraceptives: does the type of progestogen make a difference?

      CONTRACEPTION
    38. Kaunitz, AM
      Efficacy, cycle control, and safety of two triphasic oral contraceptives: Cyclessa (TM) (desogestrel/ethinyl estradiol) and Ortho-Novum (R) 7/7/7 (norethindrone/ethinyl estradiol) - A randomized clinical trial

      CONTRACEPTION
    39. Adekunle, AO; Fakokunde, AF; Arowojolu, AO; Ladipo, OA
      The effects of nomegestrol acetate subdermal implant (Uniplant (R)) on serum cholesterol, triglycerides, and lipoproteins in Nigerian users

      CONTRACEPTION
    40. Burnhill, MS
      The use of a large-scale surveillance system in Planned Parenthood Federation of America clinics to monitor cardiovascular events in users of combination oral contraceptives

      INTERNATIONAL JOURNAL OF FERTILITY AND WOMENS MEDICINE
    41. Szarewski, A; Mansour, D
      The 'pill scare': the responses of authorities, doctors and patients usingoral contraception

      HUMAN REPRODUCTION UPDATE
    42. Prasad, RNV; Koh, SCL; Viegas, OAC; Ratnam, SS
      Effects on hemostasis after two-year use of low dose combined oral contraceptives with gestodene or levonorgestrel

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    43. Timmer, CJ; Srivastava, N; Dieben, TOM; Cohen, AF
      Bioavailability and bioequivalence of etonogestrel from two oral formulations of desogestrel: Cerazette (R) and Liseta (R)

      EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
    44. Timmer, CJ; Geurts, TBP
      Bioequivalence assessment of three different estradiol formulations in postmenopausal women in an open, randomized, single-dose, 3-way cross-over study

      EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
    45. de Kleijn, MJJ; Bots, ML; Bak, AAA; Westendorp, ICD; Planellas, J; Bennink, HJTC; Witteman, JCM; Grobbee, DE
      Hormone replacement therapy in perimenopausal women and 2-year change of carotid intima-media thickness

      MATURITAS
    46. Fruzzetti, F; Giannessi, D; Ricci, C; Bernini, W; Puntoni, R; Genazzani, AR; De Caterina, R
      Platelet-vessel wall interactions with third-generation oral contraceptives: No evidence of detrimental effects

      THROMBOSIS AND HAEMOSTASIS
    47. Rechberger, T; Baranowski, W; Postawski, K; Jakimiuk, AJ; Tomaszewski, J; Kulik-Rechberger, B; Jakowicki, JA
      Serum leptin concentrations in women taking oral contraceptives

      EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY
    48. Rice, CF; Killick, SR; Dieben, T; Bennink, HC
      A comparison of the inhibition of ovulation achieved by desogestrel 75 mu g and levonorgestrel 30 mu g daily

      HUMAN REPRODUCTION
    49. Kuhl, H
      Oral contraceptives and androgenic symptoms

      GEBURTSHILFE UND FRAUENHEILKUNDE
    50. Sullivan, H; Furniss, H; Spona, J; Elstein, M
      Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 mu g) and ethinyl estradiol (15 mu g) on ovarian activity

      FERTILITY AND STERILITY
    51. Thorneycroft, IH; Stanczyk, FZ; Bradshaw, KD; Ballagh, SA; Nichols, M; Weber, ME
      Effect of low-dose oral contraceptives on androgenic markers and acne

      CONTRACEPTION
    52. Schwartz, JL; Creinin, MD; Pymar, HC
      The trimonthly combination oral contraceptive regimen: Is it cost effective?

      CONTRACEPTION
    53. Endrikat, J; Dusterberg, B; Ruebig, A; Gerlinger, C; Strowitzki, T
      Comparison of efficacy, cycle control, and tolerability of two low-dose oral contraceptives in a multicenter clinical study

      CONTRACEPTION
    54. Archer, DF
      Endometrial histology during use of a low-dose estrogen-desogestrel oral contraceptive with a reduced hormone-free interval

      CONTRACEPTION
    55. Roumen, FJME; Dieben, TOM
      Clinical acceptability of an ethylene-vinyl-acetate nonmedicated vaginal ring

      CONTRACEPTION
    56. Young, RL; DelConte, A
      Effects of low-dose monophasic levonorgestrel with ethinyl estradiol preparation on serum lipid levels: A twenty-four-month clinical trial

      AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
    57. Archer, DF; Mammen, EF; Grubb, GS
      The effects of a low-dose monophasic preparation of levonorgestrel and ethinyl estradiol on coagulation and other hemostatic factors

      AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
    58. Weiss, G
      Risk of venous thromboembolism with third-generation oral contraceptives: A review

      AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
    59. Corey, EJ; Huang, AX
      A short enantioselective total synthesis of the third-generation oral contraceptive desogestrel

      JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
    60. Gjonnaess, H
      Comparison of ovarian electrocautery and oral contraceptives in the treatment of hyperandrogenism in women with polycystic ovary syndrome

      ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
    61. Schiele, F; Vincent-Viry, M; Fournier, B; Starck, M; Siest, G
      Biological effects of eleven combined oral contraceptives on serum triglycerides, gamma-glutamyltransferase, alkaline phosphatase, bilirubin and other biochemical variables

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    62. ARCHER DF; GAST MJ
      AN INVESTIGATION OF OVULATION INHIBITION WITH A LOW-DOSE COMBINED ORAL-CONTRACEPTIVE CONTAINING 75 MU-G GESTODENE AND 20 MU-G ETHINYLESTRADIOL

      Gynecological endocrinology
    63. VANHUESDEN AM; FAUSER BCJM; SPIELMAN D
      A COMPARATIVE CLINICAL INVESTIGATION OF ENDOCRINE PARAMETERS WITH 2 LOW-DOSE ORAL-CONTRACEPTIVES CONTAINING EITHER 75 MU-G GESTODENE OR 150MU-G DESOGESTREL COMBINED WITH 20 MU-G ETHINYLESTRADIOL

      Gynecological endocrinology
    64. BLOEMENKAMP KWM; HELMERHORST FM; DERSJANTROORDA MD; DEBOER R; MEYER P; SPIELMANN D; KLUFT C
      A COMPARATIVE CLINICAL INVESTIGATION OF 2 LOW-DOSE ORAL-CONTRACEPTIVES CONTAINING EITHER 75 MU-G GESTODENE OR 150 MU-G DESOGESTREL COMBINEDWITH 20 MU-G ETHINYLESTRADIOL - EFFECT ON HEMOSTASIS, LIPID-METABOLISM AND CARBOHYDRATE-METABOLISM

      Gynecological endocrinology
    65. GAST MJ; GRUBB G
      A REVIEW OF CYCLE CONTROL WITH A LOW-DOSE ORAL-CONTRACEPTIVE CONTAINING 75 MU-G GESTODENE AND 20 MU-G ETHINYLESTRADIOL

      Gynecological endocrinology
    66. HOFFMANN H; MOORE C; ZIMMERMANN H; ELGER W; SCHWARZ S; GRASER T; OETTEL M
      APPROACHES TO THE REPLACEMENT OF ETHINYLESTRADIOL BY NATURAL 17-BETA-ESTRADIOL IN COMBINED ORAL-CONTRACEPTIVES

      Experimental and toxicologic pathology
    67. NOWACZYKDURA G; CZEKAJ P
      EFFECTS OF ETHINYLESTRADIOL AND LEVONORGESTREL ON MORPHOLOGY, ULTRASTRUCTURE AND HISTOENZYMATIC ACTIVITY OF RAT-KIDNEY

      Physiologia bohemoslovaca
    68. BLOEMENKAMP KWM; ROSENDAAL FR; HELMERHORST FM; KOSTER T; BERTINA RM; VANDENBROUCKE JP
      HEMOSTATIC EFFECTS OF ORAL-CONTRACEPTIVES IN WOMEN WHO DEVELOPED DEEP-VEIN THROMBOSIS WHILE USING ORAL-CONTRACEPTIVES

      Thrombosis and haemostasis
    69. ANDERSEN BS; OLSEN J; NIELSEN GL; STEFFENSEN FH; SORENSEN HT; BAECH J; GREGERSEN H
      3RD-GENERATION ORAL-CONTRACEPTIVES AND HERITABLE THROMBOPHILIA AS RISK-FACTORS OF NONFATAL VENOUS THROMBOEMBOLISM

      Thrombosis and haemostasis
    70. MASCARENHAS L; VANBEEK A; BENNINK HC; NEWTON J
      A 2-YEAR COMPARATIVE-STUDY OF ENDOMETRIAL HISTOLOGY AND CERVICAL CYTOLOGY OF CONTRACEPTIVE IMPLANT USERS IN BIRMINGHAM, UK

      Human reproduction (Oxford. Print)
    71. COMPARATO MR; YABUR JA; BAJARES M
      CONTRACEPTIVE EFFICACY AND ACCEPTABILITY OF A MONOPHASIC ORAL-CONTRACEPTIVE CONTAINING 30 MU-G ETHINYL ESTRADIOL AND 150 MU-G DESOGESTREL IN LATIN-AMERICAN WOMEN

      Advances in contraception
    72. ARUL GS; DOLAN G; RANCE CH; SINGH SJ; SOMMERS J
      CELIAC AXIS THROMBOSIS ASSOCIATED WITH THE COMBINED ORAL-CONTRACEPTIVE PILL - A RARE CAUSE OF AN ACUTE ABDOMEN

      Pediatric surgery international
    73. VERHOEVEN CHJ; KREBBERS SFM; WAGENAARS GN; VOS RME
      IN-VITRO AND IN-VIVO METABOLISM OF DESOGESTREL IN SEVERAL SPECIES

      Drug metabolism and disposition
    74. KUHNZ W; GIESCHEN H
      PREDICTING THE ORAL BIOAVAILABILITY OF 19-NORTESTOSTERONE PROGESTINS IN-VIVO FROM THEIR METABOLIC STABILITY IN HUMAN LIVER MICROSOMAL PREPARATIONS IN-VITRO

      Drug metabolism and disposition
    75. RING S; WEBER G; HILLISCH A; SCHWARZ S
      THE REMARKABLE INFLUENCE OF STEROID A B-RING JUNCTION ON THE WITTIG OLEFINATION REACTION OF THE 11-OXO GROUP - TOWARDS THE SYNTHESIS OF 5-ALPHA-ORIENTED AND 5-BETA-ORIENTED DELTA(3)-ISOMERS OF DESOGESTREL/

      Steroids
    76. Gentile, DM; Verhoeven, CHJ; Shimada, T; Back, DJ
      The role of CYP2C in the in vitro bioactivation of the contraceptive steroid desogestrel

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    77. CARR BR
      UNIQUENESS OF ORAL-CONTRACEPTIVE PROGESTINS

      Contraception
    78. REDMOND GP
      EFFECTIVENESS OF ORAL-CONTRACEPTIVES IN THE TREATMENT OF ACNE

      Contraception
    79. ADEN U; JUNGHOFFMANN C; KUHL H
      A RANDOMIZED CROSS-OVER STUDY ON VARIOUS HORMONAL PARAMETERS OF 2 TRIPHASIC ORAL-CONTRACEPTIVES

      Contraception
    80. WIEGRATZ I; JUNGHOFFMANN C; GROSS W; KUHL H
      EFFECT OF 2 ORAL-CONTRACEPTIVES CONTAINING ETHINYL ESTRADIOL AND GESTODENE OR NORGESTIMATE ON DIFFERENT LIPID AND LIPOPROTEIN PARAMETERS

      Contraception
    81. KLINGER G; EICK S; KLINGER G; PFISTER W; GRASER T; MOORE C; OETTEL M
      INFLUENCE OF HORMONAL CONTRACEPTIVES ON MICROBIAL-FLORA OF GINGIVAL SULCUS

      Contraception
    82. WINKLER UH; HOWIE H; BUHLER K; KORVER T; GEURTS TBP; BENNINK HJTC
      A RANDOMIZED CONTROLLED DOUBLE-BLIND-STUDY OF THE EFFECTS ON HEMOSTASIS OF 2 PROGESTOGEN-ONLY PILLS CONTAINING 75-MU-G DESOGESTREL OR 30-MU-G LEVONORGESTREL

      Contraception
    83. LAMMERS P; BLUMENTHAL PD; HUGGINS GR
      DEVELOPMENTS IN CONTRACEPTION - A COMPREHENSIVE REVIEW OF DESOGEN(R) (DESOGESTREL AND ETHINYL ESTRADIOL)

      Contraception
    84. Mascarenhas, L; van Beek, A; Bennink, HC; Newton, J
      Twenty-four month comparison of apolipoproteins A-1, A-II, and B in contraceptive implant users (Norplant (R) and Implanon (R)) in Birmingham, UnitedKingdom

      CONTRACEPTION
    85. FARMER RDT; LAWRENSON RA
      ORAL-CONTRACEPTIVES AND VENOUS THROMBOEMBOLIC DISEASE - THE FINDINGS FROM DATABASE STUDIES IN THE UNITED-KINGDOM AND GERMANY

      American journal of obstetrics and gynecology
    86. AKIN M; ARCHER D; BERGA S; BURNS L; CALKINS J; DAVIS A; DRAEGER M; FREIDENSEN H; FUNK S; GIESLER C; GORDON S; KATZ D; KHAIRI S; LEDGER W; LENIHAN J; LONDON R; MCQUARRIE H; MEDINA H; MERCER L; MILHALOV L; MONTGOMERY M; NOTELOVITZ M; PARKER G; PHILLIPS E; REZA L; SANFILLIPPO J; SAXENA B; SINGH M; SOLTES B; SOPER H; SPEROFF L; SUMMERS P; TRUPIN S; WEISSBERG S; WILLEMS J; YOUNG R
      AN OPEN-LABEL, MULTICENTER, NONCOMPARATIVE SAFETY AND EFFICACY STUDY OF MIRCETTE(TM), A LOW-DOSE ESTROGEN-PROGESTIN ORAL-CONTRACEPTIVE

      American journal of obstetrics and gynecology
    87. BERGA SL
      METABOLIC AND ENDOCRINE EFFECTS OF THE DESOGESTREL-CONTAINING ORAL-CONTRACEPTIVE MIRCETTE(TM)

      American journal of obstetrics and gynecology
    88. KILLICK SR; FITZGERALD C; DAVIS A
      OVARIAN ACTIVITY IN WOMEN TAKING AN ORAL-CONTRACEPTIVE CONTAINING 20 MU-G ETHINYL ESTRADIOL AND 150 MU-G DESOGESTREL - EFFECTS OF LOW ESTROGEN DOSES DURING THE HORMONE-FREE INTERVAL

      American journal of obstetrics and gynecology
    89. DARNEY PD
      OC PRACTICE GUIDELINES - MINIMIZING SIDE-EFFECTS

      International journal of fertility and women's medicine
    90. GALLICANO K; MCGILVERAY I
      ANALYTICAL METHODS FOR MEASUREMENT OF CONTRACEPTIVE STEROIDS IN HUMANPLASMA

      Journal of clinical ligand assay
    91. LEVESQUE H; BORG JY; COURTOIS H
      THE VASCULAR RISK OF 3RD-GENERATION ORAL- CONTRACEPTIVES

      Journal des maladies vasculaires
    92. BECKER WJ
      MIGRAINE AND ORAL-CONTRACEPTIVES

      Canadian journal of neurological sciences
    93. MILLS A
      COMBINED ORAL CONTRACEPTION AND THE RISK OF VENOUS THROMBOEMBOLISM

      Human reproduction
    94. LUCKY AW; HENDERSON TA; OLSON WH; ROBISCH DM; LEBWOHL M; SWINYER LJ
      EFFECTIVENESS OF NORGESTIMATE AND ETHINYL ESTRADIOL IN TREATING MODERATE ACNE-VULGARIS

      Journal of the American Academy of Dermatology
    95. GAO HW; SU XD; HUANG L; LI ZS
      AN IMPROVED SYNTHESIS OF 13-BETA-ETHYL-11-METHYLENEGON-4-EN-3,17-DIONE

      Synthetic communications
    96. GAO HW; SU XD; LI ZS
      SYNTHESIS OF 13-ETHYL-17-HYDROXY-11-METHYLENE-18, 19-DINOR-17-ALPHA-PREGN-4-EN-20-YN-3-ONE (3-OXO DESOGESTREL)

      Steroids
    97. GAO HW
      APPROACHES TO PARTIAL SYNTHESES OF 11-OXO STEROIDS - A BRIEF REVIEW

      Organic preparations and procedures international
    98. GAO HW; SU XD; ZHOU LM; LI ZS
      SYNTHESIS OF HYLENE-18,19-DINOR-17-ALPHA-PREGN-4-EN-20-YN-17-OL

      Organic preparations and procedures international
    99. SULAK PJ; CRESSMAN BE; WALDROP E; HOLLEMAN S; KUEHL TJ
      EXTENDING THE DURATION OF ACTIVE ORAL-CONTRACEPTIVE PILLS TO MANAGE HORMONE WITHDRAWAL SYMPTOMS

      Obstetrics and gynecology
    100. FELBERBAUM R; DIEDRICH K
      ORAL-CONTRACEPTIVES - ADVANTAGES AND RISK S

      Der Gynakologe


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 24/10/20 alle ore 20:58:04